Skip to main content
. Author manuscript; available in PMC: 2022 May 6.
Published in final edited form as: Leukemia. 2021 Nov 6;36(3):723–732. doi: 10.1038/s41375-021-01441-9

Figure 6. Pro-Inflammatory Cytokines Decrease with Treatment in Patients without Toxicity on dFCR treatment.

Figure 6.

IL-17A, IFNγ, IL-21, TNFα, IL-1RA and Tweak were statistically significantly different between tox and no tox groups.